{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:14:59Z","timestamp":1790972099367,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9-10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.2119\/molmed.2010.00256","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T21:26:47Z","timestamp":1318022807000},"page":"917-924","source":"Crossref","is-referenced-by-count":62,"title":["Rapamycin Ameliorates Dystrophic Phenotype in mdx Mouse Skeletal Muscle"],"prefix":"10.1186","volume":"17","author":[{"given":"Saman","family":"Eghtesad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Jhunjhunwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"1709917_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/gte.1998.2.55","volume":"2","author":"A Drousiotou","year":"1998","unstructured":"Drousiotou A, et al. (1998) Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Genet. Test. 2:55\u201360.","journal-title":"Genet. Test"},{"key":"1709917_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE. (1991) Population frequencies of inherited neuromuscular diseases\u2014a world survey. Neuromuscul. Disord. 1:19\u201329.","journal-title":"Neuromuscul. Disord"},{"key":"1709917_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/adc.88.1.91-b","volume":"88","author":"EP Parsons","year":"2003","unstructured":"Parsons EP, Bradley DM, Clarke AJ. (2003) Newborn screening for Duchenne muscular dystrophy. Arch. Dis. Child. 88:91\u20132.","journal-title":"Arch. Dis. Child."},{"key":"1709917_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/0140-6736(90)91364-G","volume":"335","author":"AE Emery","year":"1990","unstructured":"Emery AE. (1990) Dystrophin function. Lancet. 335:1289.","journal-title":"Lancet"},{"key":"1709917_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919\u201328.","journal-title":"Cell"},{"key":"1709917_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0098-2997(91)90001-3","volume":"12","author":"EP Hoffman","year":"1991","unstructured":"Hoffman EP, Schwartz L. (1991) Dystrophin and disease. Mol. Aspects Med. 12:175\u201394.","journal-title":"Mol. Aspects Med."},{"key":"1709917_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield G, Siller W, Wight P, Moore K. (1984) X Chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. 81:1189\u201392.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1709917_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/path.2213","volume":"213","author":"A Farini","year":"2007","unstructured":"Farini A, et al. (2007) T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid\/mdx mouse. J. Pathol. 213:229\u201338.","journal-title":"J. Pathol."},{"key":"1709917_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/clim.2000.4966","volume":"98","author":"MJ Spencer","year":"2001","unstructured":"Spencer MJ, Montecino-Rodriguez E, Dorshkind K, Tidball JG. (2001) Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin. Immunol. 98:235\u201343.","journal-title":"Clin. Immunol."},{"key":"1709917_CR10","first-page":"339","volume":"13","author":"RL Burleson","year":"1981","unstructured":"Burleson, RL, Marbarger, PD, Jermanovich, N, Brennan, AM, Scruggs, BF. (1981) A prospective study of methylprednisolone and prednisone as immunosuppressive agents in clinical renal transplantation. Transplant. Proc. 13:339\u201343.","journal-title":"Transplant. Proc."},{"key":"1709917_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1432-2277.2007.00630.x","volume":"21","author":"Y Liu","year":"2008","unstructured":"Liu Y, Chen Y, Liu FQ, Lamb JR, Tam PK. (2008) Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation. Transpl. Int. 21:483\u201394.","journal-title":"Transpl. Int."},{"key":"1709917_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/00007890-199502150-00019","volume":"59","author":"JT Vilquin","year":"1995","unstructured":"Vilquin JT, et al. (1995) Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation. 59:422\u20136.","journal-title":"Transplantation"},{"key":"1709917_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nri2546","volume":"9","author":"AW Thomson","year":"2009","unstructured":"Thomson AW, Turnquist HR, Raimondi G. (2009) Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9:324\u201337.","journal-title":"Nat. Rev. Immunol."},{"key":"1709917_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sj.ki.5002255","volume":"72","author":"C Libetta","year":"2007","unstructured":"Libetta C, et al. (2007) The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo. Kidney Int. 72:114\u201320.","journal-title":"Kidney Int."},{"key":"1709917_CR15","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","volume":"177","author":"M Battaglia","year":"2006","unstructured":"Battaglia M, et al. (2006) Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177:8338\u201347.","journal-title":"J. Immunol."},{"key":"1709917_CR16","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","volume":"105","author":"M Battaglia","year":"2005","unstructured":"Battaglia M, Stabilini A, Roncarolo MG. (2005) Rapamycin selectively expands CD4+CD25+ FoxP3+ regulatory T cells. Blood. 105:4743\u20138.","journal-title":"Blood"},{"key":"1709917_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cardiores.2005.06.025","volume":"68","author":"N Hedhli","year":"2005","unstructured":"Hedhli N, Pelat M, Depre C. (2005) Protein turnover in cardiac cell growth and survival. Cardiovasc. Res. 68:186\u201396.","journal-title":"Cardiovasc. Res."},{"key":"1709917_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0076-6879(08)03611-2","volume":"452","author":"T Ikenoue","year":"2009","unstructured":"Ikenoue T, Hong S, Inoki K. (2009) Monitoring mammalian target of rapamycin (mTOR) activity. Methods Enzymol. 452:165\u201380.","journal-title":"Methods Enzymol."},{"key":"1709917_CR19","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.2527\/jas.2007-0567","volume":"86","author":"X Yang","year":"2008","unstructured":"Yang X, et al. (2008) The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth. J. Anim. Sci. 86:E36\u201350.","journal-title":"J. Anim. Sci."},{"key":"1709917_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/138920310791824093","volume":"11","author":"H Zhou","year":"2010","unstructured":"Zhou H, Huang S. (2010) The complexes of mammalian target of rapamycin. Curr. Protein Pept. Sci. 11:409\u201324.","journal-title":"Curr. Protein Pept. Sci."},{"key":"1709917_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, et al. (2001) Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell. Biol. 3:1014\u20139.","journal-title":"Nat. Cell. Biol."},{"key":"1709917_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel C, et al. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat. Cell. Biol. 3:1009\u201313.","journal-title":"Nat. Cell. Biol."},{"key":"1709917_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/mus.21624","volume":"41","author":"E Mouisel","year":"2010","unstructured":"Mouisel E, Vignaud A, Hourde C, Butler-Browne G, Ferry A. (2010) Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18\u201324-month-old) dystrophic mdx mice. Muscle Nerve. 41:809\u201318.","journal-title":"Muscle Nerve"},{"key":"1709917_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jconrel.2008.10.011","volume":"133","author":"S Jhunjhunwala","year":"2009","unstructured":"Jhunjhunwala S, Raimondi G, Thomson AW, Little SR. (2009) Delivery of rapamycin to dendritic cells using degradable microparticles. J. Control Release. 133:191\u20137.","journal-title":"J. Control Release"},{"key":"1709917_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0960-8966(01)00198-5","volume":"11","author":"MJ Spencer","year":"2001","unstructured":"Spencer MJ, Tidball JG. (2001) Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul. Disord. 11:556\u201364.","journal-title":"Neuromuscul. Disord"},{"key":"1709917_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1432-2277.2009.00973.x","volume":"23","author":"CM Lange","year":"2010","unstructured":"Lange CM, et al. (2010) Increased frequency of regulatory T cells and selection of highly potent CD62L+ cells during treatment of human lung transplant recipients with rapamycin. Transpl. Int. 23:266\u201376.","journal-title":"Transpl. Int."},{"key":"1709917_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CND.0b013e3181d4a4f9","volume":"12","author":"T Iannitti","year":"2010","unstructured":"Iannitti T, Capone S, Feder D, Palmieri B. (2010) Clinical use of immunosuppressants in Duchenne muscular dystrophy. J. Clin. Neuromuscul. Dis. 12:1\u201321.","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"1709917_CR28","first-page":"617","volume":"18","author":"S Charfi","year":"2007","unstructured":"Charfi S, et al. (2007) Successful treatment of post-renal transplant gastric and pulmonary Ka-posi\u2019s sarcoma with conversion to rapamycin treatment. Saudi J. Kidney Dis. Transpl. 18:617\u201320.","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"1709917_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1432-2277.2003.tb00238.x","volume":"16","author":"J Iglesias","year":"2003","unstructured":"Iglesias J, et al. (2003) Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient. Transpl. Int. 16:765\u20137.","journal-title":"Transpl. Int."},{"key":"1709917_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","volume":"5","author":"N Kerkar","year":"2005","unstructured":"Kerkar N, et al. (2005) Rapamycin successfully treats post-transplant autoimmune hepatitis. Am. J. Transplant. 5:1085\u20139.","journal-title":"Am. J. Transplant"},{"key":"1709917_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.20071477","volume":"205","author":"S Haxhinasto","year":"2008","unstructured":"Haxhinasto S, Mathis D, Benoist C. (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205:565\u201374.","journal-title":"J. Exp. Med."},{"key":"1709917_CR32","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer S, et al. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U. S. A. 105:7797\u2013802.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1709917_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4049\/jimmunol.178.1.320","volume":"178","author":"L Strauss","year":"2007","unstructured":"Strauss L, et al. (2007) Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin. J. Immunol. 178:320\u20139.","journal-title":"J. Immunol."},{"key":"1709917_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/352536a0","volume":"352","author":"HH Stedman","year":"1991","unstructured":"Stedman HH, et al. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352:536\u20139.","journal-title":"Nature"},{"key":"1709917_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1113\/jphysiol.2008.163816","volume":"587","author":"MJ Drummond","year":"2009","unstructured":"Drummond MJ, et al. (2009) Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J. Physiol. 587:1535\u201346.","journal-title":"J. Physiol."},{"key":"1709917_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1083\/jcb.200903131","volume":"187","author":"V Risson","year":"2009","unstructured":"Risson V, et al. (2009) Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187:859\u201374.","journal-title":"J. Cell Biol."},{"key":"1709917_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/gt.2009.120","volume":"17","author":"B Wu","year":"2010","unstructured":"Wu B, et al. (2010) Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino. Gene Ther. 17:132\u201340.","journal-title":"Gene Ther."},{"key":"1709917_CR38","first-page":"338","volume":"8","author":"K Esser","year":"2008","unstructured":"Esser K. (2008) Regulation of mTOR signaling in skeletal muscle hypertrophy. J. Musculoskelet. Neuronal Interact. 8:338\u20139.","journal-title":"J. Musculoskelet. Neuronal Interact"},{"key":"1709917_CR39","doi-asserted-by":"publisher","first-page":"C1434","DOI":"10.1152\/ajpcell.00248.2009","volume":"297","author":"Y Ge","year":"2009","unstructured":"Ge Y, et al. (2009) mTOR regulates skeletal muscle regeneration in vivo through kinasedependent and kinase-independent mechanisms. Am. J. Physiol. Cell Physiol. 297:C1434\u201344.","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1709917_CR40","first-page":"E39","volume":"93","author":"M Pende","year":"2006","unstructured":"Pende M. (2006) mTOR, Akt, S6 kinases and the control of skeletal muscle growth. Bull. Cancer. 93:E39\u201343.","journal-title":"Bull. Cancer"},{"key":"1709917_CR41","doi-asserted-by":"publisher","first-page":"E1070","DOI":"10.1152\/ajpendo.00329.2004","volume":"287","author":"JD Fluckey","year":"2004","unstructured":"Fluckey JD, et al. (2004) Insulin facilitation of muscle protein synthesis following resistance exercise in hindlimb-suspended rats is independent of a rapamycin-sensitive pathway. Am. J. Physiol. Endocrinol. Metab. 287:E1070\u20135.","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1709917_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/path.2562","volume":"219","author":"J Robinson","year":"2009","unstructured":"Robinson J, et al. (2009) Oral rapamycin reduces tumour burden and vascularization in Lkb1(+\/\u2212) mice. J. Pathol. 219:35\u201340.","journal-title":"J. Pathol."},{"key":"1709917_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison, DE et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 460:392\u20135.","journal-title":"Nature"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2010.00256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2010.00256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T04:50:48Z","timestamp":1554526248000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2010.00256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":43,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1709917"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2010.00256","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]}}}